30 Day Trial

Seikagaku Grows in Low Double-Digits on Favorable U.S. Reimbursement Status

Share:

Seikagaku reports FY 2Q19 revenue of JPY ¥7,906MM (USD $71.4MM), +12.5% vs. 2Q18.

This article is a Member-only item of content. Members, please log in to read the complete post.
If you are not yet a Member, click here to learn more about purchasing ORTHOWORLD Membership.